Cargando…
New intranasal cross-linked mosapride xyloglucan pluronics micelles (MOS-XPMs) for reflux esophagitis disease: In-vitro optimization and improved therapeutic efficacy
Mosapride belongs to class IV in Biopharmaceutics Classification System and is used in the treatment of reflux esophagitis. It exhibits poor bioavailability due to limited permeability, solubility and extensive first-pass metabolism. In this study, intranasal mosapride-loaded cross-linked xyloglucan...
Autores principales: | Hammad, Reham Waheed, Sanad, Rania Abdel-Basset, Abdelmalak, Nevine Shawky, Torad, Faisal A., Latif, Randa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7025289/ https://www.ncbi.nlm.nih.gov/pubmed/32089877 http://dx.doi.org/10.1016/j.jare.2020.01.013 |
Ejemplares similares
-
Drug Delivery Systems Based on Pluronic Micelles with Antimicrobial Activity
por: Popovici, Corina, et al.
Publicado: (2022) -
Mosapride-Induced Movement Disorders
por: Hong, Sang-Wook, et al.
Publicado: (2022) -
Investigating the mechanism of acoustically activated uptake of drugs from Pluronic micelles
por: Husseini, Ghaleb A, et al.
Publicado: (2002) -
Effect of mosapride on ruminal motility in cattle
por: ARAI, Shozo, et al.
Publicado: (2019) -
Docetaxel-Loaded Pluronic P123 Polymeric Micelles: in Vitro and in Vivo Evaluation
por: Liu, Zhihong, et al.
Publicado: (2011)